[SHINSA]Points to Consider for Concordance Evaluation of Companion Diagnostics Using DNA Sequencers(Early Consideration)and Points to Consider for the Development of Companion Diagnostics for Drugs with Efficacy and Safety Demonstrated in Clinical Trials in Which Patients Were Enrolled Using Tests Selected by Clinical Trial Sites(Early Consideration) posted.
Imported from official source
This version
- Version
- 5 of 5
- Recorded
- November 19, 2026 00:32
- Change
- Imported change
- Content hash
9fe7d953a57cf7505761acfe43310601- All versions
- Revision history